To investigate a clinically relevant role for LAT3 in CRC, we first analyzed LAT3 mRNA levels in tumor and normal patient samples across tumor types using publicly available RNASeq data (TNMPlot pan-cancer analysis; https://tnmplot.com/analysis (27)). The gene discussed is SLC43A1; the disease is cancer.